SULFHYDRYL INHIBITORS FOR CLINICAL CANCER CHEMOTHERAPY*,†

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 15, Iss. 1, 1967-01 ,pp. : 41-50

John Wiley & Sons Inc

Access to resources Recommend Favorite

Attack of the cancer‐killing viruses: Clinical application of oncolytic virotherapy in children

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 5, 2015-05 ,pp. : 739-740

John Wiley & Sons Inc

Access to resources Recommend Favorite

Major Clinical Impact of Platinum-Based Chemotherapy in a Patient with a Borderline Ovarian Cancer

By  

Case Reports in Oncology, Vol. 2, Iss. 3, 2009-09 ,pp. : 168-171

Karger

Access to resources Recommend Favorite

CANCER CHEMOTHERAPY*

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 10, Iss. 12, 1962-12 ,pp. : 1058-1061

John Wiley & Sons Inc

Access to resources Recommend Favorite

MET amplification is not rare and predicts unfavorable clinical outcomes in patients with recurrent/metastatic gastric cancer after chemotherapy

By  

CANCER, Vol. 120, Iss. 5, 2014-03 ,pp. : 675-682

John Wiley & Sons Inc

Access to resources Recommend Favorite